COLUMBUS, Ohio – Dr. Carlo Croce (43221), who is a member of the molecular biology and cancer genetics program at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, is among 229 leaders in the sciences, social sciences, humanities, the arts, business and public affairs who have been elected to the 2010 class of the American Academy of Arts and Sciences. Croce, who also is director of human cancer genetics at The Ohio State University and the John W. Wolfe Chair in Human Cancer Genetics, will be inducted on Oct. 9 in Cambridge, Mass. The new fellows join one of the nation’s oldest and most prestigious honorary societies. A center for independent policy research, the academy is celebrating its 230th anniversary this year. Established in 1780 by John Adams and other founders of the nation, the academy undertakes studies of complex and emerging problems. Its membership of scholars and practitioners from many disciplines and professions gives it the capacity to conduct a range of interdisciplinary, long-term policy research. Current projects focus on science and technology, global security, social policy and American institutions, the humanities and culture and education. Croce, who is professor and chair of the department of molecular virology, immunology and medical genetics at the Ohio State College of Medicine, was one of the first researchers to make a case for the genetic basis for cancer through his discovery of the MYC oncogene’s role in Burkitt lymphoma. He later identified several other genes responsible for the pathogenesis of lymphoma, leukemia and other cancers. Most recently, Croce has been studying the role of small molecules known as microRNAs. A member of the National Academy of Sciences, Croce has twice been named an Outstanding Investigator by the National Cancer Institute. He is the recipient of numerous honors and prizes. The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute cancer.osu.edu is one of only 40 Comprehensive Cancer Centers in the United States designated by the National Cancer Institute. Ranked by U.S. News & World Report among the top cancer hospitals in the nation, The James is the 180-bed adult patient-care component of the cancer program at The Ohio State University. The OSUCCC-James is one of only seven funded programs in the country approved by the NCI to conduct both Phase I and Phase II clinical trials. # # # Related Links: Click here for a high-quality photograph of Dr. Carlo Croce: Eileen Scahill Medical Center Public Affairs and Media Relations 614-293-3737 Eileen.Scahill@osumc.edu